BETAC

This brand name is authorized in Cyprus, Hong Kong, Lithuania, Romania, Singapore

Active ingredients

The drug BETAC contains one active pharmaceutical ingredient (API):

1 Betaxolol UNII 6X97D2XT0O - BETAXOLOL HYDROCHLORIDE

Betaxolol is a cardioselective Beta1 receptor blocker which, when applied topically to the eye, lowers intraocular pressure. It is thought to produce this effect by reducing the rate of production of aqueous humour. Read about Betaxolol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BETAC Film-coated tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07AB05	Betaxolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 51772
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003926, 1082999, 1083000, 1083001, 1083002
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W42300001, W42300002, W42300003, W42300004
Country: SG	Health Sciences Authority	Identifier(s): 12621P